Michael Budde studied physics at Aarhus University, Aarhus, Denmark. He received the PhD degree in 1998 on experimental studies of local vibrational modes of hydrogen-related point defects in Silicon and Germanium. He then worked as post doctoral researcher for two years at Vanderbilt University, Nashville, TN, where his studies of the vibrational modes were extended into the time domain using pico-second infrared pulses from the Free Electron Laser at Jefferson Laboratory. In 2000, Michael changed research subject from semiconductor physics to quantum optics of ultracold atoms. He worked as a post doctoral researcher at Harvard University, Cambridge, MA, where he and his coworkers used slow light to create quantum shock waves in Bose-Einstein condensates. Back at Aarhus University in 2002, he established a research group, and built a laser and ultracold atom laboratory for experiments on Bose-Einstein condensates.
In 2007 Michael moved from academia to industry, when he was appointed as accelerator physicist at Danfysik A/S. Here he was part of a team that developed an accelerator system for cancer therapy with carbon ions and protons. Danfysik’s particle therapy division was transferred to Siemens Healthcare in 2008. Michael was promoted to manager of the accelerator system architect group, and in the period 2008-2012, two particle therapy accelerator system were commissioned by Michael and his team. In 2012 Michael returned to Danfysik A/S, where is now is Head of the Physics Design group.